TB-500 (synthetic Thymosin Beta-4 ) is designated strictly for laboratory research
Used to prevent and ease the feelings of nausea and vomiting that can commonly be associated with cancer treatments, post surgery, pregnancy and headaches
Here are two notable trials underlying these potential benefits: In a study involving 107 patients with alcohol (n = 47) or opiate (n = 60) withdrawal symptoms, DSIP was administered intravenously based on the hypothesis of its agonistic activity on opiate receptors
Conclusion BPC-157 is emerging as one of the most promising gut-healing peptides, with potential benefits spanning ulcers, IBS, gastritis, GERD, and IBD
Sikiri P, Seiwerth S, Grabarevi Z, Rucman R, Petek M, Jagi V, Turkovi B, Rotkvi I, Mise S, Zorici I, Gjurasin M, Konjevoda P, Separovi J, Ljubanovi D, Artukovi B, Bratuli M, Tisljar M, Jurina L, Buljat G, Mikli P, Marovi A
Yet, though this is promising, active trials are still ongoing